The Long Run with Luke Timmerman

Timmerman Report
  • 4,7 (113)
  • CIÊNCIA
  • MENSAL
The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

  1. 26 DE SET.

    Ep165: Zach Hornby on Tackling Cancer Drug Resistance

    Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.

    1h3min

  2. 5 DE SET.

    Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

    Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.

    57min

  3. 14 DE AGO.

    Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

    Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.

    1h8min

  4. 16 DE JUL.

    Ep162: Sean McClain on AI for Biologic Drug Discovery

    Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.

    1h6min

  5. 1 DE JUL.

    Ep161: Jeff Stein on a Long-Lasting Flu Drug

    Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.

    1h9min

  6. 17 DE JUN.

    Ep160: Abe Ceesay on Precision Neuroscience

    Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.

    1h9min

  7. 3 DE JUN.

    Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.

    1h7min

  8. 20 DE MAI.

    Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.

    1h1min
Ver tudo (163)

4,7
de 5
113 avaliações

Sobre

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Informações

  • Criado por
    Timmerman Report
  • Anos de atividade
    2017 - 2024
  • Episódios
    163
  • Classificação
    Livre
  • Copyright
    © All rights reserved
  • Site do podcast
    The Long Run with Luke Timmerman

Mais de HeadStepper Media

Você também pode gostar de

Para ouvir episódios explícitos, inicie sessão.

Fique por dentro deste podcast

Inicie sessão ou crie uma conta para seguir podcasts, salvar episódios e receber as atualizações mais recentes.
Selecionar um país ou região

África, Oriente Médio e Índia

Ásia‑Pacífico

Europa

América Latina e Caribe

Estados Unidos e Canadá